Linh Nguyen is a Managing Director in Synapto Ventures, Principal at Gold Nest Capital and former Director in Ginward.
As Ginward's Director, Linh has been working on company spin-outs, strategic development and international expansions. She has participated in set-up, planning and execution projects at several stages of development of biotech companies: from ideation and founding, to fundraising from seed to growth stages, to international expansion, to commercial deal negotiation and exit planning.
As the Principal of Gold Nest Capital, she sources and evaluates investment proposals within the life science industry. Based on their technical and financial potentials, she and the analyst team will provide investment recommendations for the fund committee. Linh's investment experience allowed her to work with companies from various fields within life sciences such as drug developers research tools, medical devices, digital health, etc. and even beyond healthcare with agritech, material sciences and green energy.
Prior to Ginward, Linh conducted intensive research in the Institute of Molecular and Cell Biology, A'STAR, Singapore. She focused on investigating gestational diabetes using stem cell and organoid models. She has published in international journals and presented at several international meetings such as the annual symposiums of the Singapore Stem Cell Society and the International Society for Stem Cell Research annual conferences in Melbourne and Los Angeles.
Linh was awarded a SINGA scholarship for PhD research in the National University of Singapore, as well as a MRes in Medical Biochemistry with First Class Honours from the University of Sheffield, UK.
